Xiaoxiao Ge

4.2k total citations · 2 hit papers
80 papers, 3.2k citations indexed

About

Xiaoxiao Ge is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoxiao Ge has authored 80 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 21 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoxiao Ge's work include Advanced biosensing and bioanalysis techniques (11 papers), Electrochemical sensors and biosensors (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Xiaoxiao Ge is often cited by papers focused on Advanced biosensing and bioanalysis techniques (11 papers), Electrochemical sensors and biosensors (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Xiaoxiao Ge collaborates with scholars based in China, United States and Czechia. Xiaoxiao Ge's co-authors include Shaojun Guo, Dan Du, Zhonghong Xia, Yuehe Lin, Chengzhou Zhu, Ming Cheng, Bo Ye, Jian Feng, Yu Wu and Bingbing Chen and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Xiaoxiao Ge

79 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rational Design of MXene/1T‐2H MoS₂‐C Nanohybrids for High‐Performance Lithium–Sulfur Batteries

2018 381 citations Xiaoxiao Ge, Shaojun Guo et al. profile →
Boron-doped Fe-N-C single-atom nanozymes specifically boost peroxidase-like activity

2020 311 citations Xiaoxiao Ge, Shaojun Guo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoxiao Ge China	29	1.2k	1.0k	762	714	337	80	3.2k
Pei Pei China	30	913 0.8×	585 0.6×	1.2k 1.6×	257 0.4×	376 1.1×	120	3.2k
Zachary T. Rosenkrans United States	22	1.2k 1.0×	2.1k 2.0×	1.3k 1.7×	478 0.7×	318 0.9×	39	3.5k
Qianqian Ni China	29	972 0.8×	1.0k 1.0×	1.7k 2.2×	164 0.2×	288 0.9×	54	3.3k
Ying Sun China	36	1.3k 1.0×	458 0.4×	1.2k 1.5×	554 0.8×	274 0.8×	117	3.8k
Yuan Tang China	31	735 0.6×	714 0.7×	603 0.8×	498 0.7×	245 0.7×	117	2.8k
Jiang Liu China	28	1.3k 1.1×	535 0.5×	578 0.8×	719 1.0×	1.2k 3.7×	101	3.6k
Saman Sargazi Iran	34	1.2k 1.0×	702 0.7×	960 1.3×	193 0.3×	214 0.6×	155	3.2k
Muhammad Rizwan Younis China	37	1.1k 0.9×	1.8k 1.7×	2.4k 3.1×	301 0.4×	116 0.3×	103	3.9k
Xinyang Wang China	35	1.4k 1.2×	769 0.7×	262 0.3×	266 0.4×	585 1.7×	152	3.6k
Dandan Zheng China	31	1.1k 0.9×	894 0.9×	392 0.5×	430 0.6×	205 0.6×	105	3.4k

Countries citing papers authored by Xiaoxiao Ge

Since Specialization

Citations

This map shows the geographic impact of Xiaoxiao Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiao Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiao Ge more than expected).

Fields of papers citing papers by Xiaoxiao Ge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxiao Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiao Ge. The network helps show where Xiaoxiao Ge may publish in the future.

Co-authorship network of co-authors of Xiaoxiao Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiao Ge. A scholar is included among the top collaborators of Xiaoxiao Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiao Ge. Xiaoxiao Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Kai, Jianbo Guo, Xuan Wang, et al.. (2025). A Review on Antifungal Activity of Plant Essential Oils. Phytotherapy Research. 39(8). 3736–3761. 1 indexed citations

Wu, Ke, Xiaoxiao Ge, Jieqing Li, et al.. (2024). Wip1 phosphatase activator QGC-8–52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells. Drug Resistance Updates. 79. 101196–101196. 3 indexed citations

Yan, Shuicheng, Hongkang Zhang, Xiaofeng Cao, et al.. (2024). Neuroprotection on ischemic brain injury by Mg2+/H2 released from endovascular Mg implant. Bioactive Materials. 42. 124–139. 4 indexed citations

Xue, Junli, Yan Zhang, Xudong Hu, et al.. (2024). Phase I/II safety and preliminary efficacy of PM1022, a bispecific antibody targeting PD-L1 and TIGIT, in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). e14694–e14694. 2 indexed citations

Guo, Ye, Lihua Wu, Yong Li, et al.. (2024). First-in-human phase I/II safety and preliminary efficacy of PM1032, a bispecific antibody targeting CLDN18.2 and 4-1BB, in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2662–2662. 3 indexed citations

Guo, Ye, Zishu Wang, Huan Zhou, et al.. (2024). First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors. BMC Cancer. 24(1). 444–444. 7 indexed citations

Xue, Liqiong, Wenbo Tang, Junli Xue, et al.. (2023). Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors. Frontiers in Oncology. 13. 1276009–1276009. 6 indexed citations

Ma, Yuxiang, Yuanyuan Zhao, Yang Zhang, et al.. (2023). Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer. 11(6). e006654–e006654. 34 indexed citations

Ge, Xiaoxiao, et al.. (2023). Immune‐related adverse events and outcomes among pan‐cancer patients receiving immune checkpoint inhibitors: A monocentric real‐world observational study. Cancer Medicine. 12(18). 18491–18502. 9 indexed citations

10.

Sun, Yanhua, et al.. (2023). Molecularly imprinted polymers based on calcined rape pollen and deep eutectic solvents for efficient sinapic acid extraction from rapeseed meal extract. Food Chemistry. 416. 135811–135811. 12 indexed citations

11.

Yu, Minhao, Hao Wang, Wei Zhao, et al.. (2022). Targeting type Iγ phosphatidylinositol phosphate kinase overcomes oxaliplatin resistance in colorectal cancer. Theranostics. 12(9). 4386–4398. 14 indexed citations

12.

Wu, Qiong, Gang Chen, Jing Wang, et al.. (2019). MnO2-Laden Black Phosphorus for MRI-Guided Synergistic PDT, PTT, and Chemotherapy. Matter. 1(2). 496–512. 165 indexed citations

13.

Chang, Yu‐Chung, Xiaoxiao Ge, Li‐Ju Wang, et al.. (2018). An ultra low-cost smartphone device for in-situ monitoring of acute organophosphorus poisoning for agricultural workers. Sensors and Actuators B Chemical. 275. 300–305. 16 indexed citations

14.

Jiang, Liyan, Wei Zhu, Katie Streicher, et al.. (2014). Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma. BMC Cancer. 14(1). 131–131. 27 indexed citations

15.

Ge, Xiaoxiao, et al.. (2013). Primary squamous cell carcinoma of the esophagus initially presenting as a large retroperitoneal mass: A case diagnosed as cancer of unknown primary site. Molecular and Clinical Oncology. 1(3). 503–506. 2 indexed citations

16.

Zhang, Weiying, Xiaoxiao Ge, Yong Tang, et al.. (2013). Nanoparticle-based immunochromatographic test strip with fluorescent detector for quantification of phosphorylated acetylcholinesterase: an exposure biomarker of organophosphorus agents. The Analyst. 138(18). 5431–5431. 30 indexed citations

17.

Fen, Zhu, Zilong Liu, Yingyong Hou, et al.. (2013). Primary Salivary Gland–Type Lung Cancer: Clinicopathological Analysis of 88 Cases from China. Journal of Thoracic Oncology. 8(12). 1578–1584. 78 indexed citations

18.

Ge, Xiaoxiao, et al.. (2013). Carotenoid Intake and Esophageal Cancer Risk: a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 14(3). 1911–1918. 39 indexed citations

19.

Jiang, Liyan, Jiaqi Huang, Chris Morehouse, et al.. (2013). Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients. Cancer Genetics. 206(9-10). 330–339. 14 indexed citations

20.

Li, Changyin, Lian‐Wen Qi, Ping Li, et al.. (2009). Identification of metabolites of Danggui Buxue Tang in rat urine by liquid chromatography coupled with electrospray ionization time‐of‐flight mass spectrometry. Rapid Communications in Mass Spectrometry. 23(13). 1977–1988. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact